Literature DB >> 3568694

Projection from previous studies: a Bayesian and frequentist compromise.

B W Brown, J Herson, E N Atkinson, M E Rozell.   

Abstract

We present methods that use the results of a previous study to predict the outcome of a specified comparative trial in which each subject's outcome is categorized dichotomously (e.g., response or no response). The methods can be generalized to other two-sample cases for which power can be calculated (e.g., exponential survival), and to one-sample cases such as demonstrating a minimal response rate or demonstrating superiority to a historic control. Bayesian methods are used on the results of the preliminary study to obtain a posterior distribution representing the state of knowledge of the parameters of interest. This distribution provides the probability that the experimental regimen is superior to the standard by any particular amount. The probability that a future study will demonstrate the superiority of the experimental treatment is obtained by using the posterior distribution to average the power of the test over the parameter space.

Mesh:

Year:  1987        PMID: 3568694     DOI: 10.1016/0197-2456(87)90023-7

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  7 in total

1.  Vitamin K and childhood cancer.

Authors:  R J Lilford; J G Thornton
Journal:  BMJ       Date:  1992-10-10

2.  Bayesian clinical trial design using historical data that inform the treatment effect.

Authors:  Matthew A Psioda; Joseph G Ibrahim
Journal:  Biostatistics       Date:  2019-07-01       Impact factor: 5.899

3.  Bayesian design using adult data to augment pediatric trials.

Authors:  David A Schoenfeld; Dianne M Finkelstein
Journal:  Clin Trials       Date:  2009-08       Impact factor: 2.486

4.  A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials.

Authors:  Kevin Kunzmann; Michael J Grayling; Kim May Lee; David S Robertson; Kaspar Rufibach; James M S Wason
Journal:  Am Stat       Date:  2021-04-22       Impact factor: 8.710

5.  A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials.

Authors:  Wei Zhong; Joseph S Koopmeiners; Bradley P Carlin
Journal:  Contemp Clin Trials       Date:  2013-04-11       Impact factor: 2.226

6.  Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.

Authors:  Maria M Ciarleglio; Christopher D Arendt
Journal:  Trials       Date:  2017-02-23       Impact factor: 2.279

7.  Use of a random effects meta-analysis in the design and analysis of a new clinical trial.

Authors:  Hayley E Jones; A E Ades; Alex J Sutton; Nicky J Welton
Journal:  Stat Med       Date:  2018-09-06       Impact factor: 2.373

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.